Sydney, May 27, 2025 (GLOBE NEWSWIRE) — Sydney, New South Wales – Sydney's leading removalists, Holloway Removals & Storage have extended operations to Melbourne and Brisbane over the past couple of years–a significant milestone in the company's growth. In an impressive move, the family-owned removals company have expanded their operations from their Sydney base, to […]
Holloway Removals & Storage Operations Extended to Melbourne and Brisbane GlobeNewswire May 27, 2025 Sydney, May 27, 2025 (GLOBE NEWSWIRE) — Sydney, New South Wales – Sydney's leading removalists, Holloway Removals & Storage have extended operations to Melbourne and Brisbane over the past couple of years–a significant milestone in the company's growth. In an impressive
Gcore welcomes Prof. Dr. Feiyu Xu, a leading figure with expertise in AI research and industry Gcore, theglobal edge AI, cloud, network, and security solutions provider, today announced it has strengthened its board with the addition of AI expert, Prof. Dr. Feiyu Xu. A renowned AI researcher, Prof. Dr. Xu has held pivotal leadership roles
AI Medical Technology's smartphone-based software outperforms dermatologists in clinical trials; European commercial launch begins ahead of U.S. operations in 2027 AI Medical Technology (AIM) has received CE mark approval for Dermalyser, its diagnostic decision support tool for melanoma detection. Designed for use on smartphones attached to a dermatoscope, the AI-powered tool has demonstrated superior performance
Flipster, a global cryptocurrency trading platform, announced its expansion into the Middle East region with the appointment of a regional head to drive innovation in this high-potential market. https://mma.prnewswire.com/media/2695739/Benjamin_Grolimund_General_Manager_UAE_Flipster.jpg The expansion is set against a regional backdrop ripe with growth opportunities. The Middle East region emerged as a global hub for cryptocurrency adoption with the
Recently,Qifu Technology (Nasdaq: QFIN; Hong Kong Stock Exchange: 3660), a leading Chinese fintech company, has secured the title of “Most Honored Company” in the 2025 Extel Asia (ex-Japan) Best Managed Teams rankings, a global leader in corporate governance and investor relations research (formerly associated with Institutional Investor). The company also topped several sub-categories, including “Best
At its Capital Markets Day today inKarlskoga, Sweden, Saab presents an update on its strategic priorities and progress towards capturing future growth and ensuring delivery on customer commitments. This will be achieved through continued capacity expansion, investments in digital transformation and accelerated future capabilities. Follow the presentations live today 08:30 CEST at www.saab.com/cmd. The webcast
The DJS Law Groupannounces that it is investigating claims on behalf of investors ofUnitedHealth Group Incorporated (“UnitedHealth” or “the Company”) (NYSE: UNH) for violations of the securities laws. https://mma.prnewswire.com/media/2696445/DJS_Logo.jpg INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. UnitedHealth is the subject
Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing Stelara® (ustekinumab) Injection. STARJEMZA® is Bio-Thera'sthird FDA
Modern Meadow will exhibit and present on the future of bio-design for luxury next-generation transformative materials Modern Meadow, a leader in bio-design, announced it will showcase its next-generation material, newly branded as INNOVERA™, at Global Fashion Summit, the leading international event for fashion sustainability. INNOVERA™, formerly known as BIO-VERA®, will be Modern Meadow's primary material